Assessing the value of novel therapies has been challenging and controversial using existing methods, pointing to the need for continued exploration of new approaches.
Innovation and Value Initiative
Advertisement
Articles by Innovation and Value Initiative
Advertisement
Latest Updated Articles
- For Cell and Gene Therapies, MCDA Holds Promise for Improving Equity in Value Assessment
Published: July 26th 2020 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – December 3, 2025
2
FDA Activity Recap: November 2025 Features SMA Approval, Boxed Warning for Elevidys, and More
3
ImmunoLogic, Episode 7: "Turbocharging CAR T-Cells: The IL-9 Orthogonal Signal" With Anusha Kalbasi, MD
4
Key Unknowns Remain in Cell and Gene Therapy
5
